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Abstract
In this article, we study the hypothesis testing of the blip / net
effects of treatments in a treatment sequence. We illustrate that the
likelihood ratio test and the score test may suffer from the curse of
dimensionality, the null paradox and the high-dimensional constraint
on standard parameters under the null hypothesis. On the other hand,
we construct the Wald test via a small number of point effects of
treatments in single-point causal inference. We show that the Wald
test can avoid these problems under the same assumptions as the Wald
test for testing the point effect of treatment. The simulation study
illustrates that the Wald test achieves the nominal level of type I error
and a low level of type II error. A real medical example illustrates how
to conduct the Wald test in practice.
Key words: blip effect of treatment; hypothesis testing; point effect of treat-
ment; sequential causal inference; Wald test
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1 Introduction
In many economic and medical researches, treatments are assigned in the
form of a sequence to influence an outcome of interest that occurs after
the last treatment of the sequence. Between treatments, there are often
time-dependent covariates that may be posttreatment variables of the earlier
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treatments and confounders of the subsequent treatments. The blip effect
of treatment is the causal effect of the treatment on the outcome given the
history of previous treatments and covariates while setting the subsequent
treatments at controls (Robins, 1997; Hernan and Robins, 2018). It is also
called the net effect of treatment (Wang and Yin, 2015). The blip effect
plays a central role in sequential causal inference for the following reasons.
The blip effect reveals the effect modification of covariates on the outcome,
which is of considerable interest in practice (Robin, 1997; Almirall et al.,
2010; Hernan and Robins, 2018). From the blip effect of treatment at a
particular time, we can find the optimal treatment at that time given the
previous treatments and covariates (Robin, 1997; Hernan and Robins, 2018).
From the blip effects of all treatments in the sequence, we can obtain the
causal effect of any treatment regime on the outcome and find the optimal
treatment regime (Robin, 1997; Hernan and Robins, 2018; Wang and Yin,
2019).
When estimating the blip effects via standard parameters, two problems
may occur: the curse of dimensionality and the null paradox. The curse
of dimensionality implies that if a treatment sequence is long and / or the
number of covariates is large, a huge number of standard parameters are
needed in the estimation. The null paradox implies that even if the blip effects
are all null, any unsaturated model is misspecified that imposes equalities
between standard parameters. Several methods are available to address the
two problems, which include the parametric model based on the well-known
G-formula (Taubman et al., 2009), the marginal structural model based on
the inverse probability of treatment weighting (Robins, 1999) and the doubly
robust method based on the structural nested mean model (SNMM) (Robins,
1997). SNMM describes a pattern of the blip effects and is specified as a
deterministic function indexed by a parameter vector of small dimension.
When testing the blip effects via standard parameters, additional problem
may occur: the estimation needs to be carried out under the null hypothesis,
which is expressed as a constraint among standard parameters. For a long
treatment sequence and plentiful covariates, the constraint consists of many
complex equations in standard parameters. This high-dimensional constraint
implied by the null hypothesis, together with the curse of dimensionality and
the null paradox, makes the testing problem highly difficult. Probably due
to these three problems, there are few literatures on the hypothesis testing
of the blip effects. To the best of our knowledge, only one attempt has
been made in which the authors used the doubly robust method to model
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SNMM under special circumstances, where strong assumptions are imposed
on SNMM and the method (Wallace et al., 2016).
On the other hand, Wang and Yin (2019) derived the new G-formula,
which identifies the blip effect via the point effects of treatments. The point
effect is simply the point effect of treatment in the framework of single-point
causal inference, and its estimation and hypothesis testing have been well
studied (Rosenbaum and Rubin, 1983). Hopefully, the new G-formula will
help to find a workable way of testing the blip effects.
In this article, we study the hypothesis testing of blip effects. In Section
2, we describe the hypothesis and illustrate that the likelihood ratio test
and the score test suffer from the curse of dimensionality, the null paradox
and the high-dimensional constraint on standard parameters under the null
hypothesis. In Section 3, we construct the Wald test via point effects and
show that it does not necessarily suffer from these problems. In Section 4,
we illustrate some finite sample properties of the Wald test by simulation.
In Section 5, we illustrate the application of our method via a real medical
example. In Section 6, we conclude the article with discussion.
2 Hypothesis testing of blip effects in sequen-
tial causal inference
Here we will introduce key elements of this work in Section 2.1 and review
the blip effect, the point effect and the new G-formula in Section 2.2. Then
we will explicate the hypothesis on the blip effects in Section 2.3 and finally
illustrate with an example the problems from which the likelihood ratio test
and the score test suffer.
2.1 Treatments, covariates and the outcome
Consider a set of random variables in the temporal order: (X1, Z1,X2, Z2,
. . . ,XT , ZT , Y ), where Zt are the treatment variables at times t = 1, . . . , T ,
X1 is a stationary covariate vector before Z1, Xt (t = 2, . . . , T ) are time-
dependent covariate vectors between Zt−1 and Zt, and Y is the outcome of in-
terest after the last treatment ZT . Let Z
t
1 = (Z1, . . . , Zt),X
t
1 = (X1, , . . . ,Xt),
and (XT1 ,Z
T
1 , Y ) = (X1, Z1, . . . ,XT , ZT , Y ). These variables have the real-
izations (xT1 , z
T
1 , y) = (x1, z1, . . . ,xT , zT , y).
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In the following, we will use P(.) to denote the probability distribution
of discrete variables or the density distribution of continuous variables. The
joint distribution of (XT1 ,Z
T
1 , Y ) is given by
P(xT1 , z
T
1 , y) (1)
= P(x1)P(z1 | x1) · · ·P(xT | xT−11 , zT−11 )P(zT | xT1 , zT−11 )P(y | xT1 , zT1 ).
The standard parameter for the conditional distribution P(xt | xt−11 , zt−11 ) of
covariate Xt given the history (x
t−1
1 , z
t−1
1 ) is the conditional mean E(Xt |
xt−11 , z
t−1
1 ). Let Ψxt = {E(Xt | xt−11 , zt−11 )} be the set of all these stan-
dard parameters for P(xt | xt−11 , zt−11 ) at t. The standard parameter for
P(zt | xt1, zt−11 ) is E(Zt | xt1, zt−11 ). Let Ψzt = {E(Zt | xt1, zt−11 )}. The
standard parameter for P(y | xT1 , zT1 ) is µ(xT1 , zT1 ) = E(Y | xT1 , zT1 ). Let
Ψy = {µ(xT1 , zT1 )}.
2.2 Blip effects, point effects and the new G-formula
Throughout the article, we assume that there is no unmeasured confounder
for the assignment of treatment zt (Robins, 1997; Hernan and Robins, 2018).
Although the assumption is not testable, it can be satisfied in practice. The
assumption is satisfied in sequential randomized experiments where zt is ran-
domly assigned according to a history (xt1, z
t−1
1 ) of the earlier treatments
and covariates. It is approximately satisfied in observational studies with a
sufficient array xt1 of covariates.
The blip effect φ(xt1, z
t−1
1 ; zt) is the causal effect of active treatment zt > 0
relative to control treatment zt = 0 on the outcome Y given (x
t
1, z
t−1
1 ) when
the subsequent treatments are set at controls, that is, zTt+1 = 0. Under the
assumption of no unmeasured confounders, the blip effect can be expressed
in terms of the standard parameters µ(xT1 , z
T
1 ) by the well-known G-formula
(Robins, 1997; Hernan and Robins, 2018). It can also be expressed in terms
of the point effects by the new G-formula (Wang and Yin, 2019), as described
below.
Let µ(xt1, z
t
1) = E(Y | xt1, zt1) be the conditional mean of Y given (xt1, zt1).
The point effect of treatment zt > 0 is
θ(xt1, z
t−1
1 ; zt) = µ(x
t
1, z
t−1
1 , zt)− µ(xt1, zt−11 , zt = 0). (2)
Noticeably, θ(xt1, z
t−1
1 ; zt) is simply the point effect of treatment zt in single-
point causal inference, and its estimation and hypothesis testing have been
well studied (Rosenbaum and Rubin, 1983).
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Under the assumption of no unmeasured confounders, Wang and Yin
(2019) decomposed the point effect θ(xt1, z
t−1
1 ; zt) of zt into the blip effects of
zt and the subsequent treatments z
T
t+1 by
θ(xt1, z
t−1
1 ; zt) = φ(x
t
1, z
t−1
1 ; zt) (3)
+
T∑
s=t+1
E1{φ(xst+1, zs−1t+1 ; zs) | xt1, zt−11 , zt}
−
T∑
s=t+1
E2{φ(xst+1, zs−1t+1 ; zs) | xt1, zt−11 , zt = 0},
where the conditional expectation E1(.) is with respect to P(x
s
t+1, z
s−1
t+1 , zs |
xt1, z
t−1
1 , zt) and E2(.) to P(x
s
t+1, z
s−1
t+1 , zs | xt1, zt−11 , zt = 0). Noticeably at
t = T , θ(xT1 , z
T−1
1 ; zT ) = φ(x
T
1 , z
T−1
1 ; zT ). They also derived its converse form
in which the blip effect is expressed in terms of the point effects and called
the two formulas the new G-formula for the blip effect.
2.3 Hypothesis on blip effects
Robins (Robins, 1997; Hernan and Robins, 2018) pointed out that in most
practices, the blip effects follow a certain pattern described by SNMM
φ(xt1, z
t−1
1 ; zt) = f(x
t
1, z
t−1
1 , zt;γ), t = 1, . . . , T,
where f(.) is a deterministic function of (xt1, z
t−1
1 , zt) indexed by a parameter
vector γ = (γ1, . . . , γk)
′ of small dimension called the blip effect parame-
ter. For example, a simple dose-effect relationship of SNMM is given by
φ(xt1, z
t−1
1 ; zt) = γzt, where γ is a one-dimensional vector; if there is addition-
ally the effect modification by xt, then SNMM is described by φ(x
t
1, z
t−1
1 ; zt) =
γ1zt + γ
′
2ztxt, where γ = (γ1,γ
′
2)
′ and γ2 has the same dimension as xt.
In this article, we focus on a linear SNMM, namely,
φ(xt1, z
t−1
1 ; zt) =
k∑
j=1
γjfj(x
t
1, z
t−1
1 , zt), t = 1, . . . , T. (4)
However, our method of testing γ can be extended to the non-linear SNMM.
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In sequential causal inference, it is essential to test the blip effects, or
equivalently, the blip effect parameter γ due to (4). In the rest of the article,
we test the hypotheses of the form
H0 : Hγ − ρ = 0 against H1 : Hγ − ρ 6= 0 (5)
where H is a l×k matrix with l ≤ k and ρ is a constant l-dimensional vector.
2.4 Problems with likelihood ratio test and score test
According to the well-known G-formula (Robins, 1997; Hernan and Robins,
2018), the blip effects are functions of all standard parameters for the joint
distribution (1) of the treatments, covariates and outcome. Therefore, the
likelihood ratio test on γ requires estimating all standard parameters under
a constraint implied by the hypothesis H0. The score test requires calcu-
lating the score functions for all standard parameters and evaluating these
functions at the estimates of these standard parameters obtained under the
null hypothesis H0. In the following, we illustrate three major problems of
the two tests by an example.
We consider a treatment sequence of length T = 10, in which covariates
Xt and treatments Zt are all dichotomous. Suppose the null hypothesis H0 is
such that all blip effects are equal to one another and can be described by a
blip effect parameter γ of one dimension. When testing the hypothesis by the
likelihood ratio test or the score test, we need to estimate a huge amount of
standard parameters: 220 = 1048576 standard parameters for the conditional
distribution P(y | x101 , z101 ), 219 = 524288 for P(z10 | x101 , z91), 218 = 26144 for
P(x10 | x91, z91), and 217 + · · · + 2 = 262142 for P(x91, z91) (namely, the curse
of dimensionality). Even under the null hypothesis, these standard param-
eters are essentially all different, because covariate Xt (t = 2, . . . , 10) is a
posttreatment variable of the earlier treatments Zt−11 and confounders of the
subsequent treatments Z10t (namely, the null paradox). The null hypothesis
implies a constraint consisting of 699049 equations in these standard parame-
ters (namely, the high-dimensional constraint on standard parameters under
H0).
In the next section, we will show that the Wald test has the flexibility
of allowing for estimating and testing γ via a small number of the point
effects instead of standard parameters and thus does not necessarily suffer
from these three problems.
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3 Wald test for blip effects
First, we will construct a model for the point effects indexed by the blip effect
parameter in Section 3.1. Second, we will use the model to estimate the blip
effect parameter conditional on all treatments and covariates in Section 3.2.
Third, we will use the conditional estimate to obtain the marginal estimate
of the blip effect parameter in Section 3.3. Then, we will use the asymptotic
distribution of the marginal estimate to construct the Wald test for the blip
effect parameter in Section 3.4. Finally, we introduce the practical procedure
for conducting the hypothesis test.
3.1 Model for point effects
SNMM describes a pattern of the blip effects and often has a simple form
in practice. To fix the idea, we assume that the blip effect of treatment zt
depends only on the last covariate xt. For instance, the blip effect of a blood
pressure drug (zt) usually depends only on the latest blood pressure and the
prognosis factors (xt). In this case, SNMM (4) becomes
φ(xt1, z
t−1
1 ; zt) =
k∑
j=1
γjfj(xt, zt). (6)
Furthermore, the assignment of zt often satisfies certain conditions in prac-
tice, that is, it depends only on part of the history (xt1, z
t−1
1 ). Even in ob-
servation studies, the assignment of zt can be approximated by a number of
sub randomized trials called subclasses (Rosenbaum and Rubin, 1983). To
fix the idea, we assume that it only depends on the latest covariate xt, so
that
P(xt−11 , z
t−1
1 | xt, zt) = P(xt−11 , zt−11 | xt). (7)
We will use (6) and (7) to develop our testing method. However, our method
can be applied to other SNMMs and treatment assignment conditions.
Consider the conditional mean
µ(xt, zt) = E(Y | xt, zt), (8)
where the expectation is with respect to the conditional probability P(y |
xt, zt). The point effect of zt > 0 in stratum xt is
θ(xt; zt) = µ(xt, zt)− µ(xt, zt = 0). (9)
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As well-known in single-point causal inference (Rosenbaum and Rubin, 1983),
formula (7) implies
θ(xt; zt) = E{θ(xt1, zt−11 ; zt) | xt, zt}, (10)
where the expectation is with respect to P(xt−11 , z
t−1
1 | xt, zt). In Supplement I
of Supporting Material, we also provide a proof for (10). Noticeably, θ(xt; zt)
are far fewer than θ(xt1, z
t−1
1 ; zt).
By decomposing the point effect θ(xt−1; zt) into components γj of the blip
effect parameter γ, we obtain the model for point effects
θ(xt; zt) =
k∑
j=1
γjcj(xt; zt), t = 1, . . . , T (11)
with
cj(xt; zt) = fj(xt, zt) +
T∑
s=t+1
E1{fj(xs, zs) | xt, zt}
−
T∑
s=t+1
E2{fj(xs, zs) | xt, zt = 0},
where the expectation E1(.) is with respect to P(xs, zs | xt, zt) and E2(.) to
P(xs, zs | xt, zt = 0). Noticeably at t = T , cj(xT ; zT ) = fj(xT , zT ). The
cj(xt; zt) is a sum of the contributions to component γj of γ from stratum
(xt, zt) versus (xt, zt = 0). Given all treatments and covariates (x
T
1 , z
T
1 ),
model (11) is an unsaturated model for the point effects θ(xt; zt) and indexed
by a k-dimensional blip effect parameter γ. In Supplement I of Supporting
Material, we will provide a proof for (11) by applying (6) and (7) to the new
G-formula (3).
For convenience, we use θt to denote a vector of the point effects θ(xt; zt)
for different (xt, zt) at time t. Putting all θt together, we obtain the point
effect vector θ = (θ′1, . . . , θ
′
T )
′. Let c(xt, zt) = {c1(xt, zt), . . . , ck(xt, zt)}.
We use Ct to denote the matrix with row vectors c(xt, zt) for different
(xt, zt) at time t; Putting all Ct together, we obtain the design matrix
C = (C′1, . . . ,C
′
T )
′. Then, model (11) can be written in the vector form
as
θ = Cγ. (12)
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Applying this model, we identify γ by
γ = (C′Σ−1C)−1C′Σ−1θ, (13)
where Σ is a positive definite matrix, which can be arbitrarily chosen such
that the matrix (C′Σ−1C) is invertible.
Several statements can be made about model (11) or equivalently (12).
First, the sizes of the point effect vector θ and the design matrix C are only
proportional to the length T of treatment sequence; potentially we may use
(12) to estimate the blip effect parameter γ and overcome the curse of dimen-
sionality. Second, given (xT1 , z
T
1 ) and thus C, model (12) is an unsaturated
model for the point effect vector θ and indexed by a k-dimensional parameter
vector γ = (γ1, . . . , γk)
′; potentially we may use (12) to improve the estima-
tion and overcome the null paradox. Third, the γ is the model parameter
in (12); potentially we may use (12) to estimate γ under the null hypothesis
H0, avoiding the high-dimensional constraint on standard parameters under
H0.
Let us look at the example of Section 2.4, where the treatment sequence is
T = 10, treatments and covariates are all dichotomous, and the null hypoth-
esis H0 is such that all blip effects are equal to one another and described
by a one-dimensional blip effect parameter γ. Then the point effect vector
θ consists of only 20 point effects θ(xt; zt = 1) (t = 1, . . . , 10; xt = 0, 1).
Applying (11) or (12), the point effect θ(xt; zt) decomposes into
θ(xt; zt) = c(xt; zt)γ, t = 1, . . . , 10,
where c(xt; zt) = 1+
∑10
s=t+1{P(zs = 1 | xt, zt)−P(zs = 1 | xt, zt = 0)}. Thus,
the design matrix C becomes a column vector of 20 elements c(xt; zt = 1).
Furthermore, the model is unsaturated for θ and indexed by only one param-
eter γ. Meanwhile, it is also the model under H0. In contrast, the likelihood
ratio test and the score test still suffer from the curse of dimensionality, the
null paradox and the high-dimensional constraint on standard parameters
under H0, because all the standard parameters are still involved in these
tests and the time-dependent covariates are still posttreatment variables as
well as confounders.
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3.2 Conditional estimate of blip effect parameter given
all treatments and covariates
Suppose a data of observations (xTi1, z
T
i1, yi), i = 1, . . . , n from the random
variables (XTi1,Z
T
i1, Yi) identically and independently distributed according
to distribution (1). Then we have the following complete likelihood of the
standard parameters according to (1)
L({xTi1, zTi1, yi}ni=1) = (14a)
T∏
t=1
n∏
i=1
P(xit | xt−1i1 , zt−1i1 ; Ψxt)P(zit | xti1, zt−1i1 ; Ψzt) (14b)
n∏
i=1
P(yi | xTi1, zTi1; Ψy). (14c)
We will estimate the blip effect parameter γ based on the conditional likeli-
hood (14c) in this subsection and based on the complete likelihood (14a) in
the next subsection.
The distribution P(xT1 , z
T
1 ) of treatments and covariates is estimated by
the corresponding proportion P̂(xT1 , z
T
1 ). Given {(xTi1, zTi1)}, this proportion
has no variability and is denoted by Pc(x
T
1 , z
T
1 ), where the subscript ’c’ indi-
cates that it is conditional on {(xTi1, zTi1)}. Applying Pc(xT1 , zT1 ), we identify
the conditional distribution P(y | xt, zt) by
Pc(y | xt, zt) = Ec{P(y | xT1 , zT1 ) | xt, zt},
where the expectation is with respect to Pc(x
t−1
1 , z
t−1
1 ,x
T
t+1, z
T
t+1 | xt, zt)
obtained from Pc(x
T
1 , z
T
1 ). Then, we identify the mean µ(xt, zt) by
µc(xt, zt) = Ec(Y | xt, zt), (15)
where the expectation is with respect to Pc(y | xt, zt) obtained above. Ac-
cording to (9), the point effect θ(xt; zt) is then identified by
θc(xt; zt) = µc(xt, zt)− µc(xt, zt = 0).
Therefore, the point effect vector θt is identified by θc,t which consists of
θc(xt; zt), and θ by θc which consists of θc,t. Furthermore, given the propor-
tion Pc(x
T
1 , z
T
1 ), the cj(xt, zt) and thus c(xt, zt), Ct and C are all given and
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denoted by cc,j(xt, zt), cc(xt, zt), Cc,t and Cc. According to (13), the blip
effect parameter γ is then identified by
γc = (C
′
cΣ
−1
c Cc)
−1C′cΣ
−1
c θc, (16)
where Σc is a positive definite matrix such that (C
′
cΣ
−1
c Cc) is invertible.
Based on the conditional likelihood (14c), we only need to estimate θc to
estimate γc. Formula (15) implies that we can estimate µc(xt, zt) by taking
the average of yi in stratum (xt, zt). Using µˆc(xt, zt), we obtain θˆc(xt; zt) =
µˆc(xt, zt)− µˆc(xt, zt = 0) and then θ̂c,t for all point effects at time t. Clearly,
θ̂c,t is unbiased. We may use standard softwares to obtain the covariance
matrix covc(θ̂c,t).
In Supplement I of Supporting Material, we show that for the normal
outcome,
covc(θ̂c,s; θ̂c,t) = 0, s 6= t, (17)
which means that conditional on {(xTi1, zTi1)}, the estimates of the point effects
are not correlated at different times. For the outcome of common distribu-
tions, the mean µc(xs, zs) and thus θc,s are highly robust to θc,t at time t > s,
so we assume (17) for non-normal outcomes in the following development.
This assumption only leads to a minor loss of efficiency in a regression, see,
for instance, Sen and Srivastava (1997). Furthermore, it is far weaker than
those assumptions for the variance-covariance structure used in the exist-
ing estimation methods, for instance, Almirall et al. (2010), Wallace et al.
(2016) and Wang and Yin (2019).
Putting θ̂c,t at t = 1, . . . , T together, we obtain the unbiased estimate
θ̂c for all point effects. The conditional covariance matrix covc(θ̂c) is then a
diagonal matrix with diagonal submatrices covc(θ̂c,t) at times t = 1, . . . , T .
Let Σc = covc(θ̂c). If (C
′
cΣ
−1
c Cc) is invertible, then we regress θ̂c on the
obtained design matrix Cc according to model (12) and obtain
Proposition 1 Based on the conditional likelihood (14c), the estimate for
γc is
γ̂c = (C
′
cΣ
−1
c Cc)
−1C′cΣ
−1
c θ̂c. (18)
Furthermore, the estimate is unbiased: Ec(γ̂c) = γc. The conditional covari-
ance matrix is
covc(γ̂c) = (C
′
cΣ
−1
c Cc)
−1. (19)
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Now we study the asymptotic properties of
γ̂n,c = (C
′
n,cΣ
−1
n,cCn,c)
−1C′n,cΣ
−1
n,cθ̂n,c,
where n indicates the sample size. Noticeably, θn,c,t at time t = 1, . . . , T is an
estimand in single-point causal inference. The conditions for the consistency
and asymptotic normality of its estimate θ̂n,c,t are well studied in single-point
causal inference and satisfied in most practices, see, for instance, Fahrmeir
and Tutz (1994).
If θ̂n,c,t is consistent, so is θ̂n,c. Therefore γ̂n,c is consistent with γn,c given
by (16). If the estimate θ̂n,c,t is asymptotically normal:
√
n(θ̂n,c,t−θn,c,t) d−→
N{0, ncovc(θ̂n,c,t)}, so is θ̂n,c:
√
n(θ̂n,c−θn,c) d−→ N{0, ncovc(θ̂n,c)}. There-
fore γ̂n,c is also asymptotically normal:
√
n(γ̂n,c − γn,c) d−→ N{0, ncovc(γ̂n,c)}.
However, even if γn,c may converge to γ, the asymptotic normal distribution
of γ̂n,c cannot be used to construct the Wald test for hypotheses on γ, be-
cause this distribution does not incorporate the variability of treatments and
covariates. However, in the next subsection, we will use γ̂n,c and covc(γ̂n,c)
to obtain the marginal estimate of γ and its covariance matrix based on
the complete likelihood (14a) incorporating the variability of treatments and
covariates.
3.3 Marginal estimate of blip effect parameter
Based on the complete likelihood (14a), the estimates of µ(xt, zt), θ(xt; zt),
θt, θ, cj(xt, zt), c(xt, zt), Ct, C, and finally γ are marginal estimates and
denoted by µˆ(xt, zt), θˆ(xt; zt), θ̂t, θ̂, cˆj(xt, zt), ĉ(xt, zt), Ĉt, Ĉ, and finally γ̂.
Formula (8) implies that we can obtain the estimate µˆ(xt, zt) by taking
the average of yi in stratum (xt, zt). Using µˆ(xt, zt), we obtain θˆ(xt; zt) =
µˆ(xt, zt) − µˆ(xt, zt = 0) and then θ̂t and θ̂. Comparing with µˆc(xt, zt) ob-
tained from the previous subsection, we see µˆ(xt, zt) = µˆc(xt, zt), both being
the average of yi in stratum (xt, zt). Therefore, we have θˆ(xt; zt) = θˆc(xt; zt),
and then θ̂t = θ̂c,t and θ̂ = θ̂c.
Given the proportion P̂(xT1 , z
T
1 ), then the estimates cˆj(xt, zt), ĉ(xt, zt),
Ĉt, Ĉ are given; here we use ’ ˆ ’ to emphasize that these estimates pos-
sess variabilities of treatments and covariates, namely, they have non-zero
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variances. Because P̂(xT1 , z
T
1 ) = Pc(x
T
1 , z
T
1 ), we have cˆj(xt, zt) = cc,j(xt, zt).
Therefore, we have ĉ(xt, zt) = cc(xt, zt), Ĉt = Cc,t and Ĉ = Cc.
Let Σt = E{covc(θ̂c,t)} with respect to the probability P(xT1 , zT1 ). Then
an estimate of Σt is covc(θ̂c,t): Σ̂t = covc(θ̂c,t). Take Σ as a diagonal matrix
with diagonal submatrices Σt at times t = 1, . . . , T . Recalling that Σc is the
diagonal matrix with diagonal submatrices covc(θ̂c,t) at times t = 1, . . . , T ,
we have that an estimate of Σ is Σc: Σ̂ = Σc.
Now from (13) and (18), we see γ̂ = γ̂c, implying that the marginal esti-
mate of γ is equal to the conditional estimate of γc. However, the marginal
covariance matrix cov(γ̂) which incorporates the variability of {(XTi1,ZTi1)}
is not equal to the conditional covariance matrix covc(γ̂c) which is condition
on {(XTi1,ZTi1)} and does not have such a variability.
Summarizing the above observations and applying Proposition 1, we ob-
tain
Proposition 2 Based on the complete likelihood (14a), the marginal esti-
mate of γ is
γ̂ = (Ĉ′Σ̂
−1
Ĉ)−1Ĉ′Σ̂
−1
θ̂, (20)
where θ̂ = θ̂c, Ĉ = Cc, and Σ̂ = Σc, which are based on the conditional
likelihood (14c) and given in the previous subsection. However, the marginal
estimate γ̂ is biased with γ: E(γ̂) 6= γ. The marginal covariance matrix of
γ̂ is equal to
cov(γ̂) = E{covc(γ̂c)}+ cov(γc),
in which covc(γ̂c) is given by (19) and γc by (16).
Proof: The bias is due to the Jensen’s inequality:
E{(Ĉ′Σ̂−1Ĉ)−1Ĉ′Σ̂−1θ̂}
6= [{E(Ĉ)}′{E(Σ̂)}−1E(Ĉ)]−1{E(Ĉ)}′{E(Σ̂)}−1E(θ̂).
By the law of total covariance, we can decompose the marginal covariance
matrix cov(γ̂) into two terms. The first term is the mean of the conditional
covariance matrix covc(γ̂). Due to γ̂ = γ̂c, we have covc(γ̂) = covc(γ̂c)
given by (19). Thus the first term is E{covc(γ̂c)}. The second term is
the covariance matrix of the conditional mean of γ̂. Due to γ̂ = γ̂c, the
conditional mean of γ̂ is equal to the conditional mean of γ̂c, which is equal
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to γc given by (16). Thus, the second term is cov(γc). Putting the two terms
together, we obtain the formula for cov(γ̂) in the proposition.
The bias of γ̂ is small and can be ignored in practical situations, where C
usually varies slowly with (xT1 , z
T
1 ). The small bias will also be illustrated by
simulation in Section 4. To estimate the marginal covariance matrix cov(γ̂)
in practice, we can apply the bootstrap method to formula (20).
Now we study the asymptotic properties of
γ̂n = (Ĉ
′
nΣ̂
−1
n Ĉ)
−1
n Ĉ
′
nΣ̂
−1
n θ̂n,
where n indicates the sample size. Noticeably, θn,t, Σn,t and Cn,t at time
t = 1, . . . , T are the estimands in single-point causal inference. The condi-
tions for the consistency and asymptotic normality of their estimates are well
studied in single-point causal inference and satisfied in most practices, see,
for instance, Fahrmeir and Tutz (1994).
If θ̂n,t is consistent at each time t = 1, . . . , T , so is θ̂n. If nΣ̂n,t is con-
sistent, so is nΣ̂n. If Ĉn,t is consistent, so is Ĉn. Therefore γ̂n is consistent
with
γ = (C′Σ−1C)−1C′Σ−1θ.
Furthermore, if Ĉn,t is asymptotically normal at each time t = 1, . . . , T :
√
n(Ĉn,t −Ct) d−→ N [0, ncov{Ĉn,t}],
then Ĉn is asymptotically normal:
√
n(Ĉn −C) d−→ N [0, ncov{Ĉn}].
If θ̂n,t is asymptotically normal:
√
n(θ̂n,t − θt) d−→ N [0, ncov{θ̂n,t}],
then θ̂n is also asymptotically normal:
√
n(θ̂n − θ) d−→ N [0, ncov{θ̂n}].
Because γ̂n is a smooth function of Ĉn, Σ̂n and θ̂n, also noticing that nΣ̂n and
{Ĉ′n(nΣ̂n)−1Ĉn} are invertible by study design, we have that γ̂n is asymp-
totically normal:
√
n(γ̂n − γ) d−→ N{0, ncov(γ̂n)}. (21)
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Noticeably, the assumptions above on θ̂n,t, Σ̂n,t and Ĉn,t may be weak-
ened for the consistency and asymptotic normality of γ̂, because there are
far more point effects from a treatment sequence than from a single-point
treatment. More point effects imply more information about γ. Although
it is of considerable interest particularly for a long treatment sequence, the
issue is beyond the scope of this article and will not be further investigated
here.
3.4 Wald test
Recall the hypothesis (5), that is,
H0 : Hγ − ρ = 0 against H1 : Hγ − ρ 6= 0,
where H is a l×k matrix with l ≤ k and ρ is a constant l-dimensional vector.
Applying the marginal estimate γ̂ and its covariance matrix cov(γ̂) given by
Proposition 2 in the previous subsection, we obtain the Wald statistic for the
hypothesis as
W = (Hγ̂ − ρ)′{Hcov(γ̂)H′}−1(Hγ̂ − ρ). (22)
Theorem 1 Suppose that γ̂ is asymptotically normal, namely, formula (21)
is true. Then under the null hypothesis H0, the Wald statistic W has a
limiting χ2l distribution with l degrees of freedom. Under the alternative hy-
pothesis H1, the W has a limiting noncentral χ
2
l,λ distribution with l degrees
of freedom and the noncentrality parameter λ arising from Hγ − ρ 6= 0.
For a given significance level α, the null hypothesis is rejected if W exceeds
the upper 100(1− α)% quantile of the χ2l distribution.
The obtained Wald test has the following advantages over the likelihood
ratio test and the score test.
Remark 1 First, the blip effect parameter γ is estimated via a small number
of point effects θ(xt; zt), so the curse of dimensionality does not necessarily
occur. Second, model (12) is an unsaturated model for these point effects,
so the null paradox does not necessarily occur. Third, model (12) allows for
estimating γ under the null hypothesis, so a high-dimensional constraint on
standard parameters has been avoided.
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3.5 Procedure of conducting Wald test
In practice, we can conduct the Wald test in the following four stages. In the
first stage, we find the treatment assignment condition and conduct initial
assessment of the point effects and SNMM. In the second stage, we decompose
the point effects into the blip effects to obtain a model for the point effects, as
described in Section 3.1. In the third stage, we apply the model to estimate
the blip effect parameter, as described in Section 3.2. In the fourth stage,
we apply the bootstrap method to the third stage to estimate the marginal
covariance matrix for the blip effect parameter, as described in Section 3.3,
calculate the Wald statistic and conduct the hypothesis test as described
in Section 3.4. This procedure will be illustrated by a simulation study in
Section 4 and a real medical study in Section 5.
4 Simulation study
The treatment sequence has a length of T = 3. The treatment variables are
dichotomous with Zt = 0, 1 (t = 1, 2, 3). For simplicity, we do not include
the stationary covariate X1 in the simulation. The time-dependent covari-
ates are polytomous with Xt = 0, 1, 2, 3 (t = 2, 3). After the last treatment
Z3, there is an outcome variable Y of interest. A summary of the vari-
ables is (Z1, X2, Z2, X3, Z3, Y ) in the temporal order, with their realizations
(z1, x2, z2, x3, z3, y). Conditional on (z1, x2, z2, x3, z3), the outcome Y follows
the normal, Bernoulli or Poisson distribution.
Suppose SNMM of the following form. At t = 1, there is only one
blip effect of z1 = 1: φ(z1 = 1) = γ1. At t = 2, there are four blip
effects of z2 = 1 depending only on x2 = 0, 1, 2, 3: φ(z1, x2 = j; z2 =
1) = γ2j , j = 0, 1, 2, 3. At t = 3, there are four blip effects of z3 =
1 depending only on x3 = 0, 1, 2, 3: φ(z1, x2, z2, x3 = j; z3 = 1) = γ3j ,
j = 0, 1, 2, 3. Then for this SNMM, we have the blip effect parameter
γ = (γ1, γ20, γ21, γ22, γ23, γ30, γ31, γ32, γ33)
′. Denote the true value of γ by
γ0 = (γ1,0, γ20,0, γ21,0, γ22,0, γ23,0, γ30,0, γ31,0, γ32,0, γ33,0)
′. For normal outcome,
we set the true value γ0 = (2, 3,−4,−4, 3, 3,−4,−4, 3)′; for dichotomous out-
come, γ0 = (−0.2, 0.1,−0.15,−0.15, 0.1, 0.1,−0.15,−0.15, 0.1)′; for Poisson
outcome, γ0 = (2, 4,−3,−3, 4, 4,−3,−3, 4)′.
The treatment assignment satisfies (7), that is, the assignment of z2 de-
pends only on x2 and that of z3 only on x3. Then, we have a total of nine
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point effects: one θ(z1 = 1) of z1 = 1 at time t = 1, four θ(x2; z2 = 1)
of z2 = 1 with x2 = 0, 1, 2, 3 at t = 2, and four θ(x3; z3 = 1) of z3 = 1
with x3 = 0, 1, 2, 3 at t = 3. In Supplement II of Supporting Material, we
construct the data-generating mechanism that corresponds to the treatment
assignment condition and the blip effect parameter above.
We test 10 hypotheses labeled by A through J . The null hypothesis A0:
γ1 = γ1,0; the first alternative A1: γ1 = γ1,0 + c; the second alternative
A2: γ1 = γ1,0 + 2c; where c = 1 for the normal and Poisson outcomes
and c = 0.1 for the dichotomous outcome. B0 through E0: γ2j = γ2j,0,
j = 0, 1, 2, 3, respectively; B1 through E1: γ2j = γ2j,0 + c; B2 through E2:
γ2j = γ2j,0 + 2c. F0 through I0: γ3j = γ3j,0, j = 0, 1, 2, 3, respectively; F1
through I1: γ3j = γ3j,0 + c; F2 through I2: γ3j = γ3j,0 + 2c. In particular, we
also test the equalities between the blip effects at times t = 2, 3, that is, J0:
γ2j = γ3j , j = 0, 1, 2, 3; J1: γ2j = γ3j + c; J2: γ2j = γ3j + 2c.
The sample sizes are chosen as 1000, 2000 and 3000, such that the point
effects are estimable. For every sample size, 1000 data sets are generated
to simulate the type I and II errors of each outcome type. The covariance
matrix for the blip effect parameter is estimated by using the basic bootstrap
method with only 500 replications due to our limited computing power. In
Supplement II of Supporting Material, we describe the simulation study in
detail. The relevant SAS codes used for the simulation are given in Data and
Codes of the article.
Table 1 presents the type I and II error rates of hypothesis A through J at
the significance level of 0.05. From rate0 of the null hypothesis in the table,
we see that the Wald test nearly achieves the nominal level of type I error,
despite a crude bootstrap method for the covariance matrix of the blip effect
parameter. From rate1 of the first alternative hypothesis and rate2 of the
second alternative hypothesis, we see that the type II error decreases with an
increasing sample size and an increasing difference between the alternative
and null hypotheses. Comparing columns A–E with F–I, we find that the
Wald test possesses no less powers for the blip effects of the earlier treatments
(z1 = 1 and z2 = 1) than the later treatment (z3 = 1). Considering the small
difference between the null and alternative hypotheses (1 or 2 for the normal
and Poisson outcomes and 0.1 or 0.2 for the dichotomous outcome), the Wald
test is powerful in testing the blip effects.
Table 2 presents the estimate and its variance for the blip effect parameter
obtained under no constraint or under the null hypothesis J0. For the sake
of space, we use only one sample size of 1000. From this table, we see that
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the bias of the estimated blip effect parameter is negligible. We also see a
considerable reduction in variance under the null hypothesis J0 compared to
no constraint.
5 Medical example
In Sweden, patients usually seek medical help at hospitals near their resi-
dential areas. When cancer is diagnosed, they may stay at the diagnosing
hospital or transfer to another hospital for treatment. The hospital diagnos-
ing the cancer is called home hospital while the one treating the cancer is
called treating hospital. The performance of the home and treating hospitals
is of considerable interest to patients, doctors and public health agencies.
Here, we study which types of the home and treating hospitals, large
versus small, perform better on cancer survival, where the type is determined
by the number of patients received there. The data contains the information
of 1070 stomach cancer patients from a clinical study during a period between
1988 and 1995 in hospitals located in central and northern Sweden. Stomach
cancer is highly malignant with bad prognosis and its one-year survival is a
good measure of the performance of both home and treating hospital types.
The home hospital is the treatment variable Z1 at time t = 1: z1 = 1
for large type and z1 = 0 for small type. The treating hospital is Z2 at
t = 2: z2 = 1 for large type and z2 = 0 for small type. The outcome of a
patient is Y : y = 1 for a successful one-year survival and y = 0 otherwise.
The following stationary covariates before Z1 were measured: gender (X11),
geographic area (X12) and age (X13). Gender was x11 = 1 for male and
x11 = 0 for female. Geographic area was categorized into urban (x12 = 1)
versus rural (x12 = 0). Age was a continuous variable. The time-dependent
covariate between Z1 and Z2 was cancer stage (X2), which was categorized
into the advanced stage (x2 = 1) and the early stage (x2 = 0). The data is
given in Data and Codes of the article together with the SAS code for the
analysis. In the following, we will test if the blip effects of z1 = 1 and z2 = 1
are zeros respectively.
Due to a long-term social welfare system and relatively uniform culture in
the country, the assumption of no unmeasured confounders is approximately
true for home hospital Z1, at least after conditioning on (x11, x12, x13) accord-
ing to the medical experts. Similarly, the assumption is also approximately
true for treating hospital Z2 conditional on (x11, x12, x13, z1, x2).
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In the first stage, we conduct initial assessment of the point effects and
SNMM by modeling the means µ(x11, x12, x13, z1) and µ(x11, x12, x13, z1, x2, z2)
in combination with the subject matter knowledge. It is difficult to specify
the distribution P(y | x11, x12, x13, z1) due to influences of X2 and Z2, so we
use the usual quasi likelihood approach to modeling µ(x11, x12, x13, z1), see,
for instance, Fahrmeir and Tutz (1994). The distribution P(y | x11, x12, x13, z1, x2, z2)
is binomial, which is used to model µ(x11, x12, x13, z1, x2, z2). By the usual
significance test at the significance level of 0.1, we model µ(x11, x12, x13, z1),
exclude the non-significant variables X12, and obtain
µ(x11, x13, z1) = β0 + x11β1 + x13β2 + z1θ1, (23)
where θ1 = θ(x11, x13; z1 = 1) is the point effect of z1 = 1, which is the
same for all (x11, x13). We also model µ(x11, x12, x13, z1, x2, z2), exclude the
non-significant variables X12, X13, and obtain{
µ(x11, z1, x2 = 0, z2) = β3 + x11β4 + z1β5 + z2θ20,
µ(x11, z1, x2 = 1, z2) = β6 + x11β7 + z1β8 + z2θ21,
(24)
where θ20 = θ(x11, z1, x2 = 0; z2 = 1) is the point effect of z2 = 1 when x2 = 0
and θ21 = θ(x11, z1, x2 = 1; z2 = 1) is the point effect of z2 = 1 when x2 = 1,
which are the same for all (x11, z1). Combining with the subject knowledge
from medical experts, we set an initial SNMM as

φ(x11, x13; z1 = 1) = γ1,
φ(x11, x13, z1, x2 = 0; z2 = 1) = γ20,
φ(x11, x13, z1, x2 = 1; z2 = 1) = γ21.
Here, we have the blip effect parameter γ = (γ1, γ20, γ21)
′.
In the second stage, we decompose the point effects into the blip effects.
The point effect θ1 of z1 = 1 is a sum of contributions from home hospital
z1 = 1 and treating hospital z2 = 1. Because Z2 is the last treatment variable,
the point effect of z2 = 1 is equal to the blip effect of z2 = 1, that is, θ20 = γ20
and θ21 = γ21. As a result, we have

θ1 = γ1 + γ20c20 + γ21c21,
θ20 = γ20,
θ21 = γ21,
(25)
where c20 = P(x2 = 0, z2 = 1 | z1 = 1) − P(x2 = 0, z2 = 1 | z1 = 0) and
c21 = P(x2 = 1, z2 = 1 | z1 = 1)− P(x2 = 1, z2 = 1 | z1 = 0).
19
In the third stage, we estimate the blip effect parameter γ = (γ1, γ20, γ21)
′.
The parameters θc,1, θc,20 and θc,21 are estimated by applying models (23) and
(24), where as in the earlier sections, the subscript c is added to all parameters
indicating that they are identified conditional on treatments and covariates.
The estimation is based on the binomial distribution P(y | x11, z1, x2, z2) for
both (23) and (24) and is implemented by keeping the dispersion parameter
unchanged, that is, equal to one.
The probabilities P(x2, z2 | z1) are estimated by the corresponding pro-
portions P̂(x2, z2 | z1), so we obtain cc,20 and cc,21. By regression θˆc,1, θˆc,20
and θˆc,21 on one, cc,20 and cc,21 according to (25), we obtain the estimates γˆc,1,
γˆc,20 and γˆc,21. According to Proposition 2, these estimates are respectively
equal to γˆ1, γˆ20 and γˆ21, which are based on the complete likelihood of all
treatments, covariates and outcomes.
In the fourth stage, we apply the bootstrap method to the third stage
above to obtain the marginal covariance matrix of γˆ1, γˆ20 and γˆ21. Then we
apply (22) to calculate the Wald statistics for three hypotheses, (1) γ1 = 0
against γ1 6= 0, (2) γ20 = 0 against γ20 6= 0, and (3) γ21 = 0 against γ21 6= 0.
Finally we apply Theorem 1 to test these hypotheses.
In Table 3, we present the estimates of these blip effects as well as the
95% CI and the p-values for testing the three hypotheses. For comparison,
we also present the results about the point effects. Most interestingly, from
the blip effect γ1, we see that the small home hospital might perform better
than the large home hospital, indicating that the early diagnosis of stomach
cancer depends more on the short waiting queue and awareness typically
at small home hospitals than on the advanced technology at large home
hospitals. However, from the point effect θ1, we see that the large and small
home hospital might perform equally well, and this is misleading, because
the point effect is a sum of contributions from the home and the treating
hospitals.
6 Conclusion
Due to the great need in medical and economic researches, sequential causal
inference is one of the most active areas in statistics (Hernan and Robins,
2018; An and Ding, 2018). In recent years, considerable progress has been
made in developing various estimation methods (Hernan and Robins, 2018;
An and Ding, 2018). Despite a huge volume of the literature on method-
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ology, however, there are few applications of sequential causal inference in
real medical and economic researches. In sharp contrast, single-point causal
inference plays a central role in many of these researches.
One possible reason is that some statistical tools are yet to be developed,
for instance, the hypothesis testing of the blip effects, which helps to find
a pattern for the blip effects (namely, the structural nested mean model).
In this article, we found that the hypothesis test on the blip effects can be
conducted via the point effects of treatments in the sequence. Using the fact
that the point effect is simply the point effect of treatment in single-point
causal inference, we have extended the Wald test from single-point causal
inference to sequential causal inference. Our method does not need more
assumptions than single-point causal inference and therefore should have a
broad applicability. It is also easy to implement in practice, as illustrated in
the medical example of this article.
Due to the scope of this article, we only considered the hypothesis testing
for three basic outcome types, the normal, dichotomous and Poisson out-
comes. We also restricted to additive point effects and additive blip effects.
On the other hand, methods are available for testing non-additive point ef-
fects of the outcome of various types in single-point causal inference. We
believe that our testing method can be extended to more complex settings
in the context of a treatment sequence.
Supporting Material
The material contains two supplements: Supplement I for proofs of formulas
(10), (11) and (17) and Supplement II for a description of the simulation
study in Section 4.
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Supplement I: proofs of (10), (11) and (17)
Proof of formula (10): Please notice that formula (7) implies
P(xt−11 , z
t−1
1 | xt, zt) = P(xt−11 , zt−11 | xt, zt = 0).
Averaging (2), that is,
θ(xt1, z
t−1
1 ; zt) = µ(x
t
1, z
t−1
1 , zt)− µ(xt1, zt−11 , zt = 0),
with respect to P(xt−11 , z
t−1
1 | xt, zt), we obtain
E{θ(xt1, zt−11 ; zt) | xt, zt} =
E{µ(xt1, zt−11 , zt) | xt, zt} − E{µ(xt1, zt−11 , zt = 0) | xt, zt = 0},
where the last expectation is noticeably with respect to P(xt−11 , z
t−1
1 | xt, zt =
0). On the other hand, we have E{µ(xt1, zt−11 , zt) | xt, zt} = µ(xt, zt) and
E{µ(xt1, zt−11 , zt = 0) | xt, zt = 0} = µ(xt, zt = 0). Therefore, we have
E{θ(xt1, zt−11 ; zt) | xt, zt} = µ(xt, zt)− µ(xt, zt = 0),
which is equal to θ(xt; zt) according to (9). This proves (10).
Proof of formula (11): Please notice that for any function fj(xs, zs) of
(xs, zs), the expectation E{fj(xs, zs) | xt1, zt1} with respect to P(xst+1, zst+1 |
xt1, z
t
1) is equal to E{fj(xs, zs) | xt1, zt1} with respect to P(xs, zs | xt1, zt1). Now
inserting SNMM (6) into the new G-formula (3), we obtain
θ(xt1, z
t−1
1 ; zt) =
k∑
j=1
γjcj(x
t
1, z
t−1
1 ; zt), t = 1, . . . , T,
where
cj(x
t
1, z
t−1
1 ; zt) = fj(xt, zt)
+
T∑
s=t+1
E1{fj(xs, zs) | xt1, zt−11 , zt}
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−
T∑
s=t+1
E2{fj(xs, zs) | xt1, zt−11 , zt = 0},
where the conditional expectation E1(.) is with respect to P(xs, zs | xt1, zt−11 , zt)
and E2(.) to P(xs, zs | xt1, zt−11 , zt = 0).
Now, we average both sides of the equality with respect to P(xt−11 , z
t−1
1 |
xt, zt). According to (10), the average of the left side is equal to
E{θ(xt1, zt−11 ; zt) | xt, zt} = θ(xt; zt).
The average of E1{fj(xs, zs) | xt1, zt−11 , zt} is equal to E1{fj(xs, zs) | xt, zt}.
Due to (7), the average of E2{fj(xs, zs) | xt1, zt−11 , zt = 0} is equal to the
average of E2{fj(xs, zs) | xt1, zt−11 , zt = 0} with respect to P(xt−11 , zt−11 |
xt, zt = 0), which is equal to E2{fj(xs, zs) | xt, zt = 0}. Putting these terms
together, we obtain (11).
Proof of formula (17): A special case of the point effect when zs is
dichotomous has been proved by Wang and Yin (2019). Here we extend the
proof to the point effect when zs is discrete or continuous. Conditional on
{(xTi1, zTi1)}, the point effect of treatment zs > 0 in stratum (xs1, zs−11 ) is
θc(x
s
1, z
s−1
1 ; zs) = µc(x
s
1, z
s−1
1 , zs)− µc(xs1, zs−11 , zs = 0).
We need the following lemma to prove (17).
Lemma Supposing the same variance σ2 for the outcome Y given any
(xT1 , z
T
1 ), then the conditional covariance between the estimated point effects
at different times is equal to zero, that is,
covc{θˆc(xs1, zs−11 ; zs); θˆc(xt1, zt−11 ; zt)} = 0, s 6= t.
Proof: Without a loss of generality, we assume s < t. Let S be the stratum of
observations satisfying (xsi1, z
s−1
i1 , zis) = (x
s
1, z
s−1
1 , zs); S0 for (x
t
1, z
t−1
1 , zt = 0);
S1 for (x
t
1, z
t−1
1 , zt > 0); and S2 = S \ (S1 ∪ S2). Noticeably, S0 and S1 are
disjoint, and S either contains both S0 and S1 or contains neither. If S
contains neither S0 nor S1, then the lemma is true. Therefore we only prove
the lemma when S contains both S0 and S1. Let n(.) be the number of
observations in a stratum. Then, n(S) = n(S0) + n(S1) + n(S2). Rewrite
µc(x
s
1, z
s−1
1 , zs) = µ(S), µc(x
t
1, z
t−1
1 , zt = 0) = µ(S0), µc(x
t
1, z
t−1
1 , zt > 0) =
µ(S1). Additionally, denote the mean of the outcome Y in S2 by µ(S2).
Then, the mean µ(S) is equal to
µ(S) =
n(S0)
n(S)
µ(S0) +
n(S1)
n(S)
µ(S1) +
n(S2)
n(S)
µ(S2)
24
and the estimate of µ(S) is
µˆ(S) =
n(S0)
n(S)
µˆ(S0) +
n(S1)
n(S)
µˆ(S1) +
n(S2)
n(S)
µˆ(S2).
Thus,
µˆ(S)− µ(S) = n(S0)
n(S)
{µˆ(S0)− µ(S0)}+ n(S1)
n(S)
{µˆ(S1)− µ(S1)}
+
n(S2)
n(S)
{µˆ(S2)− µ(S2)}.
On the other hand, we have θc(x
t
1, z
t−1
1 ; zt) = µ(S1)− µ(S0) and thus
θˆc(x
t
1, z
t−1
1 ; zt)− θc(xt1, zt−11 ; zt) = {µˆ(S1)− µ(S1)} − {µˆ(S0)− µ(S0)}.
Recalling that S0, S1 and S2 are disjoint, we have
covc{µˆ(S), θˆc(xt1, zt−11 ; zt)}
= Ec
[
{µˆ(S)− µ(S)}{θˆc(xt1, zt−11 ; zt)− θc(xt1, zt−11 ; zt)}
]
=
n(S1)
n(S)
Ec{µˆ(S1)− µ(S1)}2 − n(S0)
n(S)
Ec{µˆ(S0)− µ(S0)}2,
which is equal to
σ2
n(S)
− σ
2
n(S)
= 0
according to the assumption of the same variance σ2 for Y given any (xT1 , z
T
1 ).
Therefore, we have
covc{µˆ(S), θˆc(xt1, zt−11 ; zt)} = 0,
which is true for all µˆ(S) = µˆc(x
s
1, z
s−1
1 , zs). Noticeably, θˆc(x
s
1, z
s−1
1 ; zs) =
µˆc(,x
s
1, z
s−1
1 , zs)− µˆc(xs1, zs−11 , zs = 0); therefore, we have
covc{θˆc(xs1, zs−11 ; zs), θˆc(xt1, zt−11 ; zt)} = 0, s < t,
which proves the lemma.
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Now according to (10), conditional on {(xTi1, zTi1)}, we have
θˆc(xs; zs) = Ec{θˆc(xs1, zs−11 ; zs) | xs, zs},
where the expectation is with respect to Pc(x
s−1
1 , z
s−1
1 | xs, zs), and
θˆc(xt; zt) = Ec{θˆc(xt1, zt−11 ; zt) | xt, zt},
where the expectation is with respect to Pc(x
t−1
1 , z
t−1
1 | xt, zt). These expres-
sions together with the lemma above imply
covc{θˆc(xs; zs); θˆc(xt; zt)} = 0, s 6= t,
which in turn implies (17).
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Supplement II: Simulation Study in Section 4
Here, we provide details about the simulation study. In Section II.1, we
describe the testing procedure in the simulation study. In Section II.2, we
apply the procedure to the simulation. In Section II.3, we construct the
standard parameters, which generates the data. The relevant SAS codes
used for the simulation are included in Data and Codes of the article.
II.1 Testing procedure in simulation
In this simulation, SNMM is known and so is the treatment assignment condi-
tion. Hence we start from the second stage of the testing procedure described
in Section 3.5. In the second stage, we apply model (11) to decompose the
point effects into the blip effects and obtain the following formulas (26a),
(26b) and (26c):
θ(z1 = 1) = γ1 +
3∑
t=2
3∑
i=0
γticti, (26a)
where cti = P(xt = i, zt = 1 | z1 = 1)− P(xt = i, zt = 1 | z1 = 0);
θ(x2 = j; z2 = 1) = γ2j +
3∑
i=0
γ3ic3i(x2 = j), (26b)
where c3i(x2 = j) = P(x3 = i, z3 = 1 | x2 = j, z2 = 1) − P(x3 = i, z3 = 1 |
x2 = j, z2 = 0);
θ(x3 = j; z3 = 1) = γ3j. (26c)
In the third stage, we estimate the blip effect parameter γ = (γ1, γ20,
γ21, γ22, γ23, γ30, γ31, γ32, γ33)
′. Let n(xt, zt) be the number of observations in
stratum (xt, zt), and I(xt, zt) be the set of all indexes i such that (xit, zit) =
(xt, zt). For the normal outcome, we have
θˆc(xt; zt = 1) =
∑
i∈I(xt,zt=1)
yi
n(xt, zt = 1)
−
∑
i∈I(xt,zt=0)
yi
n(xt, zt = 0)
,
varc{θˆc(xt; zt = 1)} = σ
2
n(xt, zt = 1)
+
σ2
n(xt, zt = 0)
,
where σ2 is the conditional variance of Y given (z1, x2, z2, x3, z3). For the
dichotomous and Poisson outcomes, we use standard softwares to obtain
θˆc(xt; zt = 1) and varc{θˆc(xt; zt = 1)}.
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The probabilities in (26a), (26b) and (26c) are estimated by the corre-
sponding proportions, which in turn lead to evaluation of cc,2i, cc,3i, and
cc,3i(x2), i = 0, 1, 2, 3. We estimate γc by regressing the obtained θˆc(z1 = 1)
on one, cc,2i and cc,3i based on (26a); θˆc(x2; z2 = 1) on one and cc,3i(x2) based
on (26b); and θˆc(x3; z3 = 1) on one based on (26c). According to Proposition
2, the obtained conditional estimate γ̂c is equal to the marginal estimate γ̂.
In the fourth stage, we estimate the marginal covariance matrix cov(γ̂)
by applying the bootstrap method to the third stage above. With cov(γ̂)
as well as γ̂, we apply (22) to calculate the Wald statistics for hypothesis A
through J . With the obtained Wald statistic, we test the hypothesis at the
significance level α = 0.05 according to Theorem 1.
II.2 Application of testing procedure to simulation
Three data-generating mechanisms are constructed for normal, dichotomous
and Poisson outcomes using the standard parameters obtained in the next
section. The sample sizes are chosen as 1000, 2000 and 3000, such that
the point effects are estimable. For every sample size, 1000 data sets are
generated of each outcome type.
We apply the procedure described in the previous subsection to each of
these 1000 data sets and check if the type I and II errors occur for hypothesis
A through J . The covariance matrix for the blip effects is estimated by
using the bootstrap method with only 500 replications due to our limited
computing power.
From these 1000 data sets, we obtain the type I and II error rates, which
are presented in Table 1. In Table 2, we present the estimate and its vari-
ance for the blip effect under no constraint or under the null hypothesis J0:
(γ20, γ21, γ22, γ23) = (γ30, γ31, γ32, γ33).
II.3 Construction of standard parameters for normal,
dichotomous and Poisson outcomes
The probabilities of treatments and covariates are the same for the three
outcome types and presented in Table II1. Here, we will use the point effects
of treatments, the point effects of covariates and the grand mean to construct
the standard parameters for the conditional distribution of the outcome given
all treatments and covariates. These standard parameters yield true values
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of the blip effects in the simulation (Wang and Yin, 2015).
As described in Section 4, we have the following blip effects. At t = 1,
there is only one blip effect of z1 = 1: φ(z1 = 1) = γ1. At t = 2, there
are four blip effects of z2 = 1 depending only on x2 = 0, 1, 2, 3: φ(z1, x2 =
j; z1 = 1) = γ2j , j = 0, 1, 2, 3. At t = 3, there are four blip effects of
z3 = 1 depending only on x3 = 0, 1, 2, 3: φ(z1, x2, z2, x3 = j; z3 = 1) = γ3j ,
j = 0, 1, 2, 3. Inserting these blip effects into the new G-formula (3), we
obtain the formula for calculating the point effect of treatment

θ(z1 = 1) = γ1 +
∑3
t=2
∑3
i=0 γtiP(xt = i, zt = 1 | z1 = 1)
−∑3
t=2
∑3
i=0 γtiP(xt = i, zt = 1 | z1 = 0),
θ(z1, x2 = j; z2 = 1) = γ2j +
∑3
i=0 γ3iP(x3 = i, z3 = 1 | z1, x2 = j, z2 = 1)
−∑3i=0 γ3iP(x3 = i, z3 = 1 | z1, x2 = j, z2 = 0),
θ(z1, x2, z2, x3 = j; z3 = 1) = γ3j.
Using the true values of the blip effects and the probabilities of treatments
and covariates given in Table II1, we calculate these point effects of the
treatments.
The point effect of covariate x2 > 0 is ζ(z1; x2) = µ(z1, x2)−µ(z1, x2 = 0),
where µ(z1, x2) = E(Y | z1, x2). The point effect of covariate x3 > 0 is
ζ(z1, x2, z2; x3) = µ(z1, x2, z2, x3)−µ(z1, x2, z2, x3 = 0), where µ(z1, x2, z2, x3) =
E(Y | z1, x2, z2, x3). The grand mean is µ = E(Y ). According to the new
G-formula (3) or its inverse form (Wang and Yin, 2019), the blip effects are
only functions of the point effects of treatments; therefore, the point effects
ζ(z1; x2) and ζ(z1, x2, z2; x3) and the grand mean can be arbitrarily chosen to
yield the same blip effects. However, the choice should allow for an appro-
priate mean of the distribution, e.g., the mean must have a range of (0, 1)
for a dichotomous outcome.
For the normal distribution, we choose the point effects of covariates
ζ(z1; x2) =


10 + 5z1, x2 = 1
12 + 5z1, x2 = 2
13 + 5z1, x2 = 3
for z1 = 0, 1, and
ζ(z1, x2, z2; x3) =


10− 5z1 − 2z2 + 3x2, x3 = 1
12− 5z1 − 2z2 + 3x2, x3 = 2
10− 5z1 − 3z2 + 3x2, x3 = 3
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for z1 = 0, 1, z2 = 0, 1 and x2 = 0, 1, 2, 3 respectively. We choose the grand
mean as µ = −5.
For the dichotomous outcome, we choose the point effects of covariates
ζ(z1; x2) =


0.1z1, x2 = 1
0.1z1, x2 = 2
0.1z1, x2 = 3
for z1 = 0, 1, and
ζ(z1, x2, z2; x3) =


−0.1z2, x3 = 1
−0.1z2, x3 = 2
−0.1z2, x3 = 3
for z1 = 0, 1, z2 = 0, 1 and x2 = 0, 1, 2, 3. We choose the grand mean as
µ = 0.55.
For the Poisson outcome, we choose the same point effects of covariates
as those for the dichotomous outcome. As for the grand mean, we choose
µ = 20.
Finally, we use the obtained θ(zt−11 ,x
t
2; zt), ζ(z
t−1
1 ,x
t−1
2 ; xt) and µ to con-
struct the standard parameter µ(z1, x2, z2, x3, z3) by applying formula (16) of
Wang and Yin (2015), that is,
µ(z1, x2, z2, x3, z3) = −
3∑
t=1
θ(zt−11 ,x
t
2; z
∗
t = 1){P(z∗t = 1 | zt−11 ,xt2)− I(zt)}
−
3∑
t=2


∑
x∗
t
>0
ζ(zt−11 ,x
t−1
2 ; x
∗
t )P(x
∗
t | zt−11 ,xt−12 )− ζ(zt−11 ,xt−12 ; xt)

+ µ,
where I(zt) equals one when zt = 1 and zero otherwise. The obtained stan-
dard parameters are presented in Tables II2-II4 for the normal, Bernoulli
and Poisson distributions respectively.
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